Találati lista | Tudóstér

001-es BibID:	BIBFORM103008
035-os BibID:	(cikkazonosító)873899 (WOS)000836963900001 (Scopus)85135499583
Első szerző:	Csató Gábor
Cím:	Predictors of restenosis following percutaneous coronary stent implantation : the role of trimetazidine therapy / Csató Gábor, Erdei Nóra, Ványai Beatrix, Balla Tímea, Czuriga Dániel, Csanádi Zoltán, Koszegi Zsolt, Édes István, Szabó Gábor Tamás
Dátum:	2022
ISSN:	2297-055X
Megjegyzések:	Aims: In-stent restenosis (ISR) is an unresolved problem following percutaneous coronary intervention (PCI), having a negative impact on clinical outcome. The main goal of this study was to find new independent predictors that may influence the development of ISR. Methods and results: In this retrospective analysis, 653 PCI patients were involved. All patients had coronary stent implantation and a follow-up coronary angiography. Based on the presence of ISR at follow-up, patients were divided into two groups: 221 in the ISR and 432 in the control group. When evaluating the medical therapy of patients, significantly more patients were on trimetazidine (TMZ) in the control compared to the ISR group (p = 0.039). TMZ was found to be an independent predictor of a lower degree of ISR development (p = 0.007). TMZ treatment was especially e??ective in baremetal stent (BMS)-implanted chronic coronary syndrome (CCS) patients with narrow coronary arteries. The inflammation marker neutrophil to lymphocyte ratio (NLR) was significantly elevated at baseline in the ISR group compared to controls. The reduction of post-PCINLR was associated with improved e cacy of TMZ to prevent ISR development. Drug eluting stent implantation (p<0.001) and increased stent diameter (p<0.001) were themost important independent predictors of a lower degree of ISR development, while the use of longer stents (p = 0.005) was a major independent predictor of an increased ISR risk. Conclusion: TMZ reduces the occurrence of ISR following PCI, with special e??ectiveness in BMS-implanted patients having CCS and narrow coronary arteries. TMZ treatmentmay help to lower ISR formation in countries with high BMS utilization rates.
Tárgyszavak:	Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban folyóiratcikk in-stent restenosis trimetazidine (TMZ) percutaneous coronary intervention (PCI) anti-inflammatory effect stent implantation
Megjelenés:	Frontiers in Cardiovascular Medicine. - 9 (2022), p. 1-9. -
További szerzők:	Erdei Nóra (1979-) (orvos) Ványai Beatrix (1993-) (általános orvos) Balla Tímea Czuriga Dániel (1982-) (kardiológus) Csanádi Zoltán (1960-) (kardiológus) Kőszegi Zsolt (1962-) (kardiológus, belgyógyász) Édes István (1952-) (kardiológus) Szabó Gábor Tamás (1982-) (kardiológus)
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:

001-es BibID:	BIBFORM100404
035-os BibID:	(cikkazonosító)784220
Első szerző:	Kőszegi Zsolt (kardiológus, belgyógyász)
Cím:	Anatomical Assessment vs. Pullback REsting full-cycle rAtio (RFR) Measurement for Evaluation of Focal and Diffuse CoronarY Disease : rationale and Design of the "READY Register" / Kőszegi Zsolt, Berta Balázs, Tóth Gábor G., Tar Balázs, Üveges Áron, Ágoston András, Szücs Attila, Szabó Gábor Tamás, Barta Judit, Szük Tibor, Czuriga Dániel, Komócsi András, Ruzsa Zoltán
Dátum:	2021
ISSN:	2297-055X 2297-055X
Megjegyzések:	Background: The morphology and functional severity of coronary stenosis show poor correlation. However, in clinical practice, the visual assessment of the invasive coronary angiography is still the most common means for evaluating coronary disease. The fractional flow reserve (FFR), the coronary flow reserve (CFR), and the resting full-cycle ratio (RFR) are established indices to determine the hemodynamic significance of a coronary stenosis. Design/Methods: The READY register (NCT04857762) is a prospective, multicentre register of patients who underwent invasive intracoronary FFR and RFR measurement. The main aim of the registry is to compare the visual estimate of coronary lesions and the functional severity of the stenosis assessed by FFR, as well as the RFR pullback. Characterizations of the coronary vessel for predominantly focal, diffuse, or mixed type disease according to visual vs. RFR pullback determination will be compared. The secondary endpoint of the study is a composite of major adverse cardiac events, including death, myocardial infarction, and repeat coronary revascularization at 1 year. These endpoints will be compared in patients with non-ischemic FFR in the subgroup of cases where the local pressure drop indicates a focal lesion according to the definition of ?RFR > 0.05 (for <25 mm segment length) and in the subgroup without significant ?RFR. In case of an FFR value above 0.80, an extended physiological analysis is planned to diagnose or exclude microvascular disease using the CFR/FFR index. This includes novel flow dynamic modeling for CFR calculation (CFRp-3D). Conclusion: The READY register will define the effect of RFR measurement on visual estimation-based clinical decision-making. It can identify a prognostic value of ?RFR during RFR pullback, and it would also explore the frequency of microvascular disease in the patient population with FFR > 0.80. Clinical Trial Registration: ClinicalTrials.gov (NCT04857762).
Tárgyszavak:	Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban folyóiratcikk resting full-cycle ratio (RFR) microvascular coronary disease fractional flow reserve (FFR) coronary flow reserve (CFR) coronary artery disease
Megjelenés:	Frontiers in Cardiovascular Medicine. - 8 (2021), p. 1-7. -
További szerzők:	Berta Balázs Tóth Gábor G. Tar Balázs (1970-) (orvos) Üveges Áron Ágoston András Szücs Attila Szabó Gábor Tamás (1982-) (kardiológus) Barta Judit (1975-) (kardiológus) Szűk Tibor (1967-) (kardiológus) Czuriga Dániel (1982-) (kardiológus) Komócsi András Ruzsa Zoltán
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon: